Comparison of Hypoxemic rate between patients using High Flow Nasal Cannula and conventional canula oxygenation during Endoscopic Retrograde Cholangiopancreatography (ERCP)

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20250901001

Enrollment

300

Registered

2025-09-01

Start date

2025-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory complication during HFNC with and without HFNC HFNC, ERCP, desaturation, respiratory intervention, ASA class I or II

Interventions

Currently, there is a new generation of HFNC machines specifically designed for peri-operative procedures, such as the Optiflow THRIVE. These machines differ from the AIRVO, which is used in research

Active Comparator Device,Active Comparator Device

HFNC,LFNC

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria - Participants aged 18-75 years who underwent endoscopic biliary and pancreatic endoscopy at the Centers of Excellence in Gastrointestinal Endoscopy at Chulalongkorn Hospital, Sawanpracharak Hospital, and Surin Hospital. - Participants were at low risk for complications of anesthesia, as defined by the American Society of Anesthesiologists Physical Status Classification (ASA Class 1 and 2).

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1. Participants were intubated before or during the procedure. 2. Participants were unable to lie prone during the procedure. 3. Participants with a history of allergy to sedatives or intravenous anesthesia. 4. Morbid obesity 5. Diagnosed or suspected of having obstructive sleep apnea based on the STOPBANGS questionnaire. 6. Pulmonary hypertension (or suspected pulmonary hypertension). 7. Cardiac disease or pulmonary edema that is currently being treated. 8. Coagulation disorders, defined as a platelet count below 50,000 or an INR > 2.5 after treatment. 9. Participants who were unable to stop antiplatelet and/or anticoagulant medications within the recommended timeframe prior to biliary and pancreatic endoscopy. 10. Participants who were pregnant. 11. Participants with a respiratory infection.

Design outcomes

Primary

Measure	Time frame
hypoxemia during ERCP pulse oximeter	—

Secondary

Measure	Time frame
respiratory intervention during ERCP nasal or tracheal secure airway	—

Countries

Thailand

Contacts

Public ContactAniwat Saleepol

King Chulalongkorn Memorial Hospital

aniwatsaleepol@gmail.com0653254242

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026